Gunsu Aydin
Overview
Explore the profile of Gunsu Aydin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sezer Z, Pavel S, Inal A, Yetiskin H, Kaplan B, Uygut M, et al.
Vaccines (Basel)
. 2024 Feb;
12(2).
PMID: 38400124
Vaccine-induced immunity wanes over time and warrants booster doses. We investigated the long-term (32 weeks) immunogenicity and safety of a third, homologous, open-label booster dose of TURKOVAC, administered 12 weeks...
2.
Ozdarendeli A, Sezer Z, Pavel S, Inal A, Yetiskin H, Kaplan B, et al.
Vaccine
. 2022 Dec;
41(2):380-390.
PMID: 36460536
Background: Development of safe and effective vaccine options is crucial to the success of fight against COVID-19 pandemic. Herein, we report interim safety and immunogenicity findings of the phase 1&2...
3.
Pavel S, Yetiskin H, Uygut M, Aslan A, Aydin G, Inan O, et al.
Vaccines (Basel)
. 2021 Nov;
9(11).
PMID: 34835197
The rapid spread of SARS-CoV-2 with its mutating strains has posed a global threat to safety during this COVID-19 pandemic. Thus far, there are 123 candidate vaccines in human clinical...
4.
Pavel S, Yetiskin H, Aydin G, Holyavkin C, Uygut M, Dursun Z, et al.
PLoS One
. 2020 Sep;
15(9):e0238614.
PMID: 32936826
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and associated with severe respiratory illness emerged in Wuhan, China, in late 2019. The virus has been...